Sanofi-Aventis U.S. LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$56Mgeneral payments (2019-2025)
$1.1Mresearch payments (2019-2025)
105,437clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| John Jenkins | Arlington, VA | $2,868,985.15 | |
| Mauricio Gonzalez-Arias | Austin, TX | Geriatric Medicine (Internal Medicine) | $824,796.24 |
| Dorry Segev | Baltimore, MD | Surgery | $821,455.36 |
| Juan Frias | San Diego, CA | Endocrinology, Diabetes & Metabolism | $743,072.64 |
| Nicola Hanania | Houston, TX | Pulmonary Disease | $509,317.24 |
| Julio Rosenstock | Dallas, TX | Endocrinology, Diabetes & Metabolism | $415,509.75 |
| Steven Edelman | San Diego, CA | Internal Medicine | $394,073.82 |
| Martin Stevens | Ann Arbor, MI | $382,255.65 | |
| Randy Lieberman | Detroit, MI | Clinical Cardiac Electrophysiology | $373,944.29 |
| Helen Baron | Rancho Mirage, CA | Endocrinology, Diabetes & Metabolism | $345,154.44 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.